최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.33 no.9, 2023년, pp.754 - 765
박지아 (경성대학교 제약공학과) , 최윤식 (경성대학교 약학과)
Exosomes are a type of extracellular vesicle containing proteins and messenger and microRNAs; they are secreted by all cell types. Once released, exosomes are selectively taken up by other cells adjacent or at a distance, releasing their contents and reprogramming the target cells. Since exosomes ar...
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal,?S. and Wood, M. J. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat.?Biotechnol. 29, 341-345.?
Anderson, H. C. 1969. Vesicles associated with calcification in the matrix of epiphyseal cartilage. J. Cell Biol. 41, 59-72.?
Bonucci, E. 1967. Fine structure of early cartilage calcifi- cation. J. Ultrastruct. Res. 20, 33-50.?
Cai, H., Pang, Y., Wang, Q., Qin, W., Wei, C., Li, Y.,?Li, T., Li, F., Wang, Q., Li, Y., Wei, Y. and Jia, L. 2022.?Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease. Alzheimers?Res. Ther. 14, 181.?
Chen, B., Song, L., Yang, J., Zhou, W. Y., Cheng, Y. Y.?and Lai, Y. J. 2023. Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive?impairment. Neural. Regen. Res. 18, 587-593.?
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E.,?Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J.,?Segaliny, A., Riazifar, M., Pham, V., Digman, M. A.,?Pone, E. J. and Zhao, W. 2016. Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol. Bioeng. 9, 509-529.?
Choi, H., Choi, K., Kim, D. H., Oh, B. K., Yim, H., Jo,?S. and Choi, C. 2022. Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Phar- maceutics 14, 672.?
Citterio, L. A., Mancuso, R., Agostini, S., Meloni, M. and?Clerici, M. 2023. Serum and exosomal miR-7-1-5p and?miR-223-3p as possible biomarkers for Parkinson's disease.?Biomolecules 13, 865.?
Couch, Y., Buzas, E. I., Di Vizio, D., Gho, Y. S., Harrison,?P., Hill, A. F., Lotvall, J., Raposo, G., Stahl, P. D., Thery, C., Witwer, K. W. and Carter, D. R. F. 2021. A brief?history of nearly EV-erything - The rise and rise of extracellular vesicles. J. Extracell. Vesicles 10, e12144.?
Du, S., Guan, Y., Xie, A., Yan, Z., Gao, S., Li, W., Rao,?L., Chen, X. and Chen, T. 2023. Extracellular vesicles: a rising star for therapeutics and drug delivery. J. Nanobiotechnology 21, 231.?
Ebrahimkhani, S., Vafaee, F., Young, P. E., Hur, S. S.?J., Hawke, S., Devenney, E., Beadnall, H., Barnett, M.?H., Suter, C. M. and Buckland, M. E. 2017. Exosomal?microRNA signatures in multiple sclerosis reflect disease?status. Sci. Rep. 7, 14293.?
Elsharkasy, O. M., Nordin, J. Z., Hagey, D. W., de Jong,?O. G., Schiffelers, R. M., Andaloussi, S. E. and Vader,?P. 2020. Extracellular vesicles as drug delivery systems:?why and how? Adv. Drug. Deliv. Rev. 159, 332-343.?
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer,?A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R.?C., Federoff, H. J., Miller, B. L. and Goetzl, E. J. 2015.?Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 11, 600-607.?
Geng, T., Pan, P., Leung, E., Chen, Q., Chamley, L. and?Wu, Z. 2021. Recent advancement and technical challenges in developing small extracellular vesicles for cancer drug delivery. Pharm. Res. 38, 179-197.?
Ghorai, S. M., Deep, A., Magoo, D., Gupta, C. and Gupta,?N. 2023. Cell-penetrating and targeted peptides delivery?systems as potential pharmaceutical carriers for enhanced?delivery across the blood-brain barrier (BBB). Pharmaceutics 15, 1999.?
Giugliani, R., Giugliani, L., de Oliveira Poswar, F., Donis,?K. C., Corte, A. D., Schmidt, M., Boado, R. J., Nestrasil,?I., Nguyen, C., Chen, S. and Pardridge, W. M. 2018.?Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52?weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial. Orphanet J. Rare Dis. 13, 110.?
Gui, Y., Liu, H., Zhang, L., Lv, W. and Hu, X. 2015.?Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget?6, 37043-37053.?
Gurung, S., Perocheau, D., Touramanidou, L. and Baruteau,?J. 2021. The exosome journey: from biogenesis to uptake?and intracellular signalling. Cell Commun. Signal. 19, 47.?
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R.,?Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky,?M., Kabanov, A. V. and Batrakova, E. V. 2015. Exosomes as drug delivery vehicles for Parkinson's disease therapy.?J. Control. Release 207, 18-30.?
Huang, L. Y., Song, J. X., Cai, H., Wang, P. P., Yin, Q.?L., Zhang, Y. D., Chen, J., Li, M., Song, J. J., Wang,?Y. L., Luo, L., Wang, W. and Qi, S. H. 2022. Healthy?serum-derived exosomes improve neurological outcomes?and protect blood-brain barrier by inhibiting endothelial?cell apoptosis and reversing autophagy-mediated tight?junction protein reduction in rat stroke model. Front. Cell?Neurosci. 16, 841544.?
Huang, S., Ge, X., Yu, J., Han, Z., Yin, Z., Li, Y., Chen,?F., Wang, H., Zhang, J. and Lei, P. 2018. Increased?miR-124-3p in microglial exosomes following traumatic?brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. FASEB. J. 32, 512-528.?
Kooijmans, S. A., Vader, P., van Dommelen, S. M., van Solinge, W. W. and Schiffelers, R. M. 2012. Exosome?mimetics: a novel class of drug delivery systems. Int. J.?Nanomedicine 7, 1525-1541.?
Li, H., Ding, Y., Huang, J., Zhao, Y., Chen, W., Tang,?Q., An, Y., Chen, R. and Hu, C. 2023. Angiopep-2 modified exosomes load rifampicin with potential for treating?central nervous system tuberculosis. Int. J. Nanomedicine?18, 489-503.?
Li, N., Shu, J., Yang, X., Wei, W. and Yan, A. 2022.?Exosomes derived from M2 microglia cells attenuates neuronal impairment and mitochondrial dysfunction in Alzheimer's disease through the PINK1/Parkin pathway.?Front. Cell Neurosci. 16, 874102.?
Li, Q., Wang, Z., Xing, H., Wang, Y. and Guo, Y. 2021.?Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease.?Mol. Ther. Nucleic Acids. 23, 1334-1344.?
Lin, X. M., Wang, Z. J., Lin, Y. X. and Chen, H. 2021.?Decreased exosome-delivered miR-486-5p is responsible?for the peritoneal metastasis of gastric cancer cells by promoting EMT progress. World J. Surg. Oncol. 19, 312.?
Liu, K., Dou, R., Yang, C., Di, Z., Shi, D., Zhang, C., Song,?J., Fang, Y., Huang, S., Xiang, Z., Zhang, W., Wang, S.?and Xiong, B. 2023. Exosome-transmitted miR-29a induces colorectal cancer metastasis by destroying the vascular endothelial barrier. Carcinogenesis 44, 356-367.?
Lu, Z., Hou, J., Li, X., Zhou, J., Luo, B., Liang, S., Lo,?R. K., Wong, T. M. and Kuang, G. M. 2022. Exosome-derived miRNAs as potential biomarkers for prostate bone?metastasis. Int. J. Gen. Med. 15, 5369-5383.?
Lugli, G., Cohen, A. M., Bennett, D. A., Shah, R. C.,?Fields, C. J., Hernandez, A. G. and smalheiser, N. R. 2015.?Plasma exosomal miRNAs in persons with and without?Alzheimer disease: altered expression and prospects for?biomarkers. PLoS One 10, e0139233.?
Malekian, F., Shamsian, A., Kodam, S. P. and Ullah, M.?2022. Exosome engineering for efficient and targeted drug delivery: Current status and future perspective. J. Physiol. doi: 10.1113/JP282799.?
McLellan, A. D. 2009. Exosome release by primary B?cells. Crit. Rev. Immunol. 29, 203-217.?
Metselaar, J. M. and Storm, G. 2005. Liposomes in the?treatment of inflammatory disorders. Expert Opin. Drug?Deliv. 2, 465-476.?
Nakano, M., Kubota, K., Kobayashi, E., Chikenji, T. S.,?Saito, Y., Konari, N. and Fujimiya, M. 2020. Bone marrow-derived mesenchymal stem cells improve cognitive?impairment in an Alzheimer's disease model by increasing?the expression of microRNA-146a in hippocampus. Sci.?Rep. 10, 10772.?
Pardridge, W. M. 2020. Treatment of Alzheimer's disease?and blood-brain barrier drug delivery. Pharmaceuticals?(Basel) 13, 394.?
Pajouhesh, H. and Lenz, G. R. 2005. Medicinal chemical?properties of successful central nervous system drugs.?NeuroRx. 2, 541-553.?
Pan, R., Chen, D., Hou, L., Hu, R. and Jiao, Z. 2023. Small?extracellular vesicles: a novel drug delivery system for?neurodegenerative disorders. Front. Aging Neurosci. 15, 1184435.?
Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J.,?Hearn, S. A., Danforth, D., Hastings, M. L. and Duelli,?D. M. 2010. Selective release of microRNA species from?normal and malignant mammary epithelial cells. PLoS One?5, e13515.?
Qin, J. and Xu, Q. 2014. Functions and application of exosomes. Acta. Pol. Pharm. 71, 537-543.?
Qiu, Y., Li, P., Zhang, Z. and Wu, M. 2021. Insights into?exosomal non-coding RNAs sorting mechanism and clinical application. Front. Oncol. 11, 664904.?
Qu, Ma., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S.,?Fu, Y., Yang, S., Zhang, Z., Zhang, L. and Sun, X. 2018.?Dopamine-loaded blood exosomes targeted to brain for?better treatment of Parkinson's disease. J. Control. Release?287, 156-166.?
Rani, A., O'shea, A., Ianov, L., Cohen, R. A., Woods,?A. J. and Foster, T. C. 2017. miRNA in circulating micro- vesicles as biomarkers for age-related cognitive decline.?Front. Aging Neurosci. 9, 323.?
Re, F., Cambianica, I., Sesana, S., Salvati, E., Cagnotto,?A., Salmona, M., Couraud, P. O., Moghimi, S. M.,?Masserini, M. and Sancini, G. 2011. Functionalization?with ApoE-derived peptides enhances the interaction with?brain capillary endothelial cells of nanoliposomes binding?amyloid-beta peptide. J. Biotechnol. 156, 341-346.?
Record, M., Subra, C., Silvente-Poirot, S. and Poirot, M. 2011. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81, 1171-1182.?
Sadeghi, S., Tehrani, F. R., Tahmasebi, S., Shafiee, A.?and Hashemi, S. M. 2023. Exosome engineering in cell?therapy and drug delivery. Inflammopharmacology 31, 145-169.?
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y.,?Sood, A. K. and Hua, S. 2015. Advances and challenges?of liposome assisted drug delivery. Front. Pharmacol. 6, 286.?
Shim, K. H., Go, H. G., Bae, H., Jeong, D. E., Kim, D.,?Youn, Y. C., Kim, S., An, S. S. A. and Kang, M. J. 2021.?Decreased exosomal acetylcholinesterase activity in the?plasma of patients with Parkinson's disease. Front. Aging?Neurosci. 13, 665400.?
Soleymani, T., Chen, T. Y., Gonzalez-Kozlova, E. and?Dogra, N. 2023. The human neurosecretome: extracellular?vesicles and particles (EVPs) of the brain for intercellular?communication, therapy, and liquid-biopsy applications.?Front. Mol. Biosci. 10, 1156821.?
Song, P., Sun, H., Chen, H., Wang, Y. and Zhang, Q. 2020.?Decreased serum exosomal miR-152-3p contributes to the?progression of acute ischemic stroke. Clin. Lab. 66, doi: 10.7754/Clin.Lab.2020.200106.
Song, Y., Li, Z., He, T., Qu, M., Jiang, L., Li, W., Shi,?X., Pan, J., Zhang, L., Wang, Y., Zhang, Z., Tang, Y.?and Yang, G. Y. 2019. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury?via exosomal miR-124. Theranostics 9, 2910-2923.?
Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau,?G., Paillasse, M., De Medina, P., Monsarrat, B., Perret,?B., Silvente-Poirot, S., Poirot, M. and Record, M. 2010.?Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J.?Lipid Res. 51, 2105-2120.?
Sun, C. N. 1966. Lattice structures and osmiophilic bodies?in the developing respiratory tissue of rats. J. Ultrastructure Res. 15, 380-388.?
Szebeni, J. and Moghimi, S. M. 2009. Liposome triggering?of innate immune responses: a perspective on benefits and?adverse reactions. J. Liposome Res. 19, 85-90.?
sTan, L., Yu, J. T., Tan, M. S., Liu, Q. Y., Wang, H.?F., Zhang, W., Jiang, T. and Tan, L. 2014. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J. Alzheimers Dis. 40, 1017-1027.?
Taylor, D. D. and Gercel-Taylor, C. 2014. Exosome platform for diagnosis and monitoring of traumatic brain?injury. Philos. Trans. R. Soc. B Biol. Sci. 369, doi: 10.1098/rstb.2013.0503.?
Trams, E. G., Lauter, C. J., Salem, N. Jr. and Heine, U. 1981. Exfoliation of membrane ecto-enzymes in the form?of micro-vesicles. Biochim. Biophys. Acta. 645, 63-70.?
Treat, L. H., McDannold, N., Zhang, Y., Vykhodtseva, N.?and Hynynen, K. 2012. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.?Ultrasound Med. Biol. 38, 1716-1725.?
Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee,?J. J. and Lotvall, J. O. 2007. Exosome-mediated transfer?of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659.?
Wang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J. and Zhao, L. 2019. Curcumin-primed exosomes potently?ameliorate cognitive function in AD mice by inhibiting?hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway. Nanoscale 11, 7481-7496.?
Wang, Y., Niu, H., Li, L., Han, J., Liu, Z., Chu, M., Sha,?X. and Zhao, J. 2023. Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis. J.?Nanobiotechnology 21, 109.?
Wei, H., Xu, Y., Xu, W., Zhou, Q., Chen, Q., Yang, M.,?Feng, F., Liu, Y., Zhu, X., Yu, M. and Li, Y. 2018. Serum?exosomal miR-223 serves as a potential diagnostic and?prognostic biomarker for dementia. Neuroscience 379, 167-176.?
Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y.,?Wang, X., Shang, X., Zhang, Z. G. and Chopp, M. 2012.?Exosome-mediated transfer of miR-133b from multipotent?mesenchymal stromal cells to neural cells contributes to?neurite outgrowth. Stem Cells 30, 1556-1564.?
Xin, H., Liu, Z., Buller, B., Li, Y., Golembieski, W., Gan,?X., Wang, F., Lu, M., Ali, M. M., Zhang, Z. G. and Chopp,?M. 2021. MiR-17-92 enriched exosomes derived from?multipotent mesenchymal stromal cells enhance axonmyelin remodeling and motor electrophysiological recovery after stroke. J. Cereb. Blood Flow Metab. 41, 1131-1144.?
Xin, H., Li, Y., Liu, Z., Wang, X., Shang, X., Cui, Y.,?Zhang, Z. G. and Chopp, M. 2013. MiR-133b promotes?neural plasticity and functional recovery after treatment?of stroke with multipotent mesenchymal stromal cells in?rats via transfer of exosome-enriched extracellular particles. Stem Cells 31, 2737-2746.?
Xiong, W. P., Yao, W. Q., Wang, B. and Liu, K. 2021.?BMSCs-exosomes containing GDF-15 alleviated SH-SY5Y?cell injury model of Alzheimer's disease via AKT/GSK-3β/β-catenin. Brain Res. Bull. 177, 92-102.?
Xu, X., Zhuang, C. and Chen, L. 2020. Exosomal long?non-coding RNA expression from serum of patients with?acute minor stroke. Neuropsychiatr. Dis. Treat. 16, 153-160.?
Yagi, Y., Ohkubo, T., Kawaji, H., Machida, A., Miyata,?H., Goda, S., Roy, S., Hayashizaki, Y., Suzuki, H. and?Yokota, T. 2017. Next-generation sequencing-based small?RNA profiling of cerebrospinal fluid exosomes. Neurosci.?Lett. 636, 48-57.?
Yang, J., Hao, J., Lin, Y., Guo, Y., Liao, K., Yang, M.,?Cheng, H., Yang, M. and Chen, K. 2022. Profile and functional prediction of plasma exosome-derived circRNAs?from acute ischemic stroke patients. Front. Genet. 13, 810974.?
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman,?K., Phipps, R., Yin, V. P., Lockman, P. and Bai, S. 2015.?Exosome delivered anticancer drugs across the blood-brain?barrier for brain cancer therapy in Danio rerio. Pharm.?Res. 32, 2003-2014.?
Zhang, H., Wang, Y., Lv, Q., Gao, J., Hu, L. and He,?Z. 2018. MicroRNA-21 Overexpression promotes the neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage. Front. Neurol. 9, 931.?
Zhang, W., Liu, Q. Y., Haqqani, A. S., Leclerc, S., Liu,?Z., Fauteux, F., Baumann, E., Delaney, C. E., Ly, D., Star,?A. T., Brunette E., Sodia, C., Hewitt, M., Sandhu, J. K.?and Stanimirovic, D. B. 2020. Differential expression of?receptors mediating receptor-mediated transcytosis (RMT)?in brain microvessels, brain parenchyma and peripheral?tissues of the mouse and the human. Fluids. Barriers CNS. 17, 47.?
Zhang, Y., Bi, J., Huang, J., Tang, Y., Du, S. and Li,?P. 2020. Exosome: A Review of its classification, isolation?techniques, storage, diagnostic and targeted therapy applications. Int. J. Nanomedicine 15, 6917-6934.?
Zhang, Y., Liu, Y., Liu, H. and Tang, W. H. 2019. Exosomes: biogenesis, biologic function and clinical potential.?Cell Biosci. 9, 19.?
Zheng, X., Sun, K., Liu, Y., Yin, X., Zhu, H., Yu, F. and?Zhao, W. 2023. Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia.?Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. J. Control. Release 353, 675-684.?
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S.,?Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L.,?Miller, D. and Zhang, H. G. 2011. Treatment of brain inflammatory diseases by delivering exosome encapsulated?anti-inflammatory drugs from the nasal region to the brain.?Mol. Ther. 19, 1769-1779.?
Zuchero, Y. J., Chen, X., Bien-Ly, N., Bumbaca, D., Tong,?R. K., Gao, X., Zhang, S., Hoyte, K., Luk, W., Huntley,?M. A., Phu, L., Tan, C., Kallop, D., Weimer, R. M., Lu,?Y., Kirkpatrick, D. S., Ernst, J. A., Chih, B., Dennis, M.?S. and Watts, R. J. 2016. Discovery of novel blood-brain?barrier targets to enhance brain uptake of therapeutic?antibodies. Neuron 89, 70-82.?
※ AI-Helper는 부적절한 답변을 할 수 있습니다.